Mio Sakuma Selected Research

Mio Sakuma Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2011
11	Atherosclerosis 01/2022 - 06/2011
7	Drug-Related Side Effects and Adverse Reactions 12/2022 - 02/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2011
4	Dyslipidemias (Dyslipidemia) 01/2020 - 02/2017
3	Neoplasms (Cancer) 01/2021 - 09/2017
3	Hypertension (High Blood Pressure) 02/2017 - 01/2012
2	Obesity 01/2020 - 02/2011
2	Brain Infarction 04/2015 - 01/2007
2	Brain Ischemia (Cerebral Ischemia) 01/2007 - 11/2005
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2024
1	Disease Progression 04/2024
1	Hematologic Diseases (Blood Diseases) 09/2022
1	Rheumatic Diseases (Rheumatism) 09/2022
1	Osteoporosis 09/2022
1	Hypercholesterolemia 01/2022
1	Hypertriglyceridemia 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Dementia (Dementias) 01/2020
1	Peptic Ulcer (Peptic Ulcers) 01/2020
1	Insulin Resistance 01/2020
1	Diabetes Mellitus 12/2019
1	Muscular Diseases (Myopathy) 01/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2018
1	Hemorrhage 02/2017
1	Hemorrhagic Stroke 02/2017
1	Asthma (Bronchial Asthma) 03/2016
1	Eczema 03/2016
1	Rhinitis 03/2016
1	Stroke (Strokes) 04/2015
1	Ischemic Stroke 04/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2013
1	Malnutrition (Nutritional Deficiencies) 05/2013
1	Proteinuria 05/2013
1	Wounds and Injuries (Trauma) 06/2012
1	Hypersensitivity (Allergy) 01/2012
1	Diabetic Angiopathies (Diabetic Angiopathy) 06/2011
1	Hyperlipidemias (Hyperlipidemia) 02/2011
1	Thrombosis (Thrombus) 01/2007
1	Paralysis (Palsy) 01/2007
1	Germinoma 10/2006
1	Transient Ischemic Attack 11/2005
1	Ischemia 11/2005

Drug/Important Bio-Agent (IBA)

10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 06/2011
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2018
7	anagliptinIBA 01/2022 - 11/2019
7	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 11/2019
5	LDL CholesterolIBA 01/2022 - 02/2011
3	oxidized low density lipoproteinIBA 01/2022 - 11/2019
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 01/2020
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2016
3	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 01/2018 - 06/2011
2	C-Reactive ProteinIBA 01/2020 - 09/2013
2	Hypnotics and Sedatives (Sedatives)IBA 01/2020 - 09/2017
2	CreatinineIBA 01/2016 - 01/2012
1	AntibodiesIBA 04/2024
1	GlucocorticoidsIBA 09/2022
1	Diphosphonates (Bisphosphonates)IBA 09/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	Proprotein Convertase 9IBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 07/2021
1	HDL CholesterolIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Fatty Acid-Binding ProteinsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	AdipokinesIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019
1	Lipoproteins (Lipoprotein)IBA 12/2019
1	DystrophinIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 09/2017
1	Dihydrotachysterol (AT 10)IBA 03/2016
1	AlbuminsIBA 01/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2015
1	Angiotensin Receptor AntagonistsIBA 04/2015
1	Serum AlbuminIBA 05/2013
1	AllergensIBA 01/2012
1	Immunoglobulin E (IgE)IBA 01/2012
1	Insulin (Novolin)FDA Link 06/2011
1	Kynurenic Acid (Kynurenate)IBA 01/2007
1	RNA (Ribonucleic Acid)IBA 01/2007
1	salicylhydroxamic acid (SHAM)IBA 01/2007
1	Glycine Receptors (Glycine Receptor)IBA 01/2007
1	Prednisolone (Predate)FDA LinkGeneric 10/2006
1	Oxidoreductases (Dehydrogenase)IBA 11/2005
1	pitavastatin (itavastatin)FDA Link 11/2005
1	ParvalbuminsIBA 11/2005
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 11/2005
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 11/2005
1	ChemokinesIBA 04/2005

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2006
5	Medication Errors (Medication Error) 12/2022 - 02/2011
3	Length of Stay 04/2024 - 06/2012
2	Chemoprevention 01/2021 - 01/2018
2	Glycemic Control 02/2017 - 06/2011
1	Polypharmacy 07/2021
1	Secondary Prevention 04/2015
1	Protein-Restricted Diet (Diet, Protein Restricted) 05/2013
1	Long-Term Care 06/2012